title: Proteomic research of high-glucose-activated endothelial microparticles and related proteins to Alzheimer's disease.
abstract: The study was designed to discover the biological function of endotheliocyte-derived microparticles in diabetes condition. A quantitative shotgun proteomics methodology was performed to study the proteome of these high-glucose-activated endothelial microparticles. A total of 1428 proteins were identified, containing 1421 and 1423 proteins in control and high-glucose groups, respectively. According to the ExoCarta database, 669 proteins have previously been identified in microparticles. The proteins associated with disease were identified in this study, and notably, 30 proteins have been reported to be associated with Alzheimer's disease, including amyloid beta A4 protein. Besides, the peptide abundance of amyloid beta A4 protein from control group was much less than that from high-glucose group. In conclusion, this work revealed the proteome of endothelial microparticles in mimic diabetes condition and provided a new proteomic evidence for Alzheimer's disease to be counted as the type 3 diabetes.
authors.affiliation: Department of Cardiology, Peking University Third Hospital, Beijing, China.
authors.forename: Lingyun
authors.initials: L
authors.lastname: Zu
authors.affiliation: Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Peking University Health Science Center, Beijing, China.
authors.forename: Chenguang
authors.initials: C
authors.lastname: Niu
authors.affiliation: Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Peking University Health Science Center, Beijing, China.
authors.forename: Jizhao
authors.initials: J
authors.lastname: Li
authors.affiliation: Key Laboratory of Cardiovascular Disease and Molecular Intervention and Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
authors.forename: Liyang
authors.initials: L
authors.lastname: Shan
authors.affiliation: Cleveland Clinic Lerner Research Institute Proteomics Laboratory, Cleveland, OH, USA.
authors.forename: Ling
authors.initials: L
authors.lastname: Li
authors.affiliation: Cleveland Clinic Lerner Research Institute Proteomics Laboratory, Cleveland, OH, USA.
authors.forename: Dongmei
authors.initials: D
authors.lastname: Zhang
authors.affiliation: Cleveland Clinic Lerner Research Institute Proteomics Laboratory, Cleveland, OH, USA.
authors.forename: Belinda
authors.initials: B
authors.lastname: Willard
authors.affiliation: Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Peking University Health Science Center, Beijing, China zhengl@bjmu.edu.cn.
authors.forename: Lemin
authors.initials: L
authors.lastname: Zheng
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D055252:Cell-Derived Microparticles / Q000378:metabolism*; D002478:Cells, Cultured; D005947:Glucose / Q000378:metabolism; D006801:Humans; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics / Q000379:methods
chemical_list: D016229:Amyloid beta-Peptides; D020543:Proteome; D005947:Glucose
keywords: Alzheimer’s disease; diabetes; endothelial microparticles; high glucoses; proteome